Abstract
Making reliable predictions of drug metabolites requires detailed knowledge of the chemical reactivity of drug metabolizing enzymes. Cytochrome P450 enzymes (P450s) play an important role in drug metabolism. Numerous adverse drug reactions have been identified that occur as a result of interactions with P450s. These enzymes display complex reactivity and the active oxidizing species is highly reactive and difficult to isolate, making P450s ideal candidates for computational study. Hybrid quantum mechanics/molecular mechanics calculations (QM/MM) have provided valuable insight into the reactivity of P450s, and will assist in the development of simpler predictive models. QM/MM methods have been used to model the metabolism of several drug molecules in human P450s, and have successfully rationalized experimentally observed selectivity. QM/MM calculations have been used to investigate the reactivity of other drug metabolizing enzymes, such as soluble epoxide hydrolase and glutathione transferases. Here, we review the application of QM/MM methods to modelling reactions catalyzed by drug metabolizing enzymes.
Keywords: Cytochrome P450, drug metabolism, enzymes, epoxide hydrolase, modelling, quantum mechanics/molecular mechanics, selectivity.
Current Topics in Medicinal Chemistry
Title:QM/MM Modelling of Drug-Metabolizing Enzymes
Volume: 14 Issue: 11
Author(s): Richard Lonsdale and Adrian J. Mulholland
Affiliation:
Keywords: Cytochrome P450, drug metabolism, enzymes, epoxide hydrolase, modelling, quantum mechanics/molecular mechanics, selectivity.
Abstract: Making reliable predictions of drug metabolites requires detailed knowledge of the chemical reactivity of drug metabolizing enzymes. Cytochrome P450 enzymes (P450s) play an important role in drug metabolism. Numerous adverse drug reactions have been identified that occur as a result of interactions with P450s. These enzymes display complex reactivity and the active oxidizing species is highly reactive and difficult to isolate, making P450s ideal candidates for computational study. Hybrid quantum mechanics/molecular mechanics calculations (QM/MM) have provided valuable insight into the reactivity of P450s, and will assist in the development of simpler predictive models. QM/MM methods have been used to model the metabolism of several drug molecules in human P450s, and have successfully rationalized experimentally observed selectivity. QM/MM calculations have been used to investigate the reactivity of other drug metabolizing enzymes, such as soluble epoxide hydrolase and glutathione transferases. Here, we review the application of QM/MM methods to modelling reactions catalyzed by drug metabolizing enzymes.
Export Options
About this article
Cite this article as:
Lonsdale Richard and Mulholland J. Adrian, QM/MM Modelling of Drug-Metabolizing Enzymes, Current Topics in Medicinal Chemistry 2014; 14 (11) . https://dx.doi.org/10.2174/1568026614666140506114859
DOI https://dx.doi.org/10.2174/1568026614666140506114859 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
AlphaFold in Medicinal Chemistry: Opportunities and Challenges
AlphaFold, a groundbreaking AI tool for protein structure prediction, is revolutionizing drug discovery. Its near-atomic accuracy unlocks new avenues for designing targeted drugs and performing efficient virtual screening. However, AlphaFold's static predictions lack the dynamic nature of proteins, crucial for understanding drug action. This is especially true for multi-domain proteins, ...read more
Artificial intelligence for Natural Products Discovery and Development
Our approach involves using computational methods to predict the potential therapeutic benefits of natural products by considering factors such as drug structure, targets, and interactions. We also employ multitarget analysis to understand the role of drug targets in disease pathways. We advocate for the use of artificial intelligence in predicting ...read more
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Current Trends in Drug Discovery Based on Artificial Intelligence and Computer-Aided Drug Design
Drug development discovery has faced several challenges over the years. In fact, the evolution of classical approaches to modern methods using computational methods, or Computer-Aided Drug Design (CADD), has shown promising and essential results in any drug discovery campaign. Among these methods, molecular docking is one of the most notable ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Renal Nerve Ablation for Hypertensive Patients with Chronic Kidney Disease
Current Vascular Pharmacology Racing of the Biological Pacemaker
Recent Patents on DNA & Gene Sequences Gene Therapy Targeting Inflammation in Atherosclerosis
Current Pharmaceutical Design Possible Role of Vascular Risk Factors in Alzheimer's Disease and Vascular Dementia
Current Pharmaceutical Design Endothelial Dysfunction and the Effects of TNF Inhibitors on the Endothelium in Psoriasis and Psoriatic Arthritis: A Systematic Review
Current Pharmaceutical Design A Review on Molecular Mechanisms and Patents of Marine-derived Anti-thrombotic Agents
Current Drug Targets Dysregulation of LncRNAs in Placenta and Pathogenesis of Preeclampsia
Current Drug Targets The Treatment of Cardiovascular Disease Continuum: Focus on Pharmacologic Management and RAS Blockade
Current Clinical Pharmacology Artery of Percheron Infarction: A Characteristic Pattern of Ischemia and Variable Clinical Presentation: A Literature Review
Current Medical Imaging Formulation, Characterization and In Vivo Evaluation of Self-Nanoemulsifying Drug Delivery System for Oral Delivery of Valsartan
Current Nanoscience Immunophilins are Involved in the Altered Platelet Aggregation Observed in Patients with Type 2 Diabetes Mellitus
Current Medicinal Chemistry Is the Carotid Plaque Rupture a Pivotal Event in Stroke Pathogenesis? Update on the Role of the Intraplaque Inflammatory Processes
Current Vascular Pharmacology Effective Delivery of Male Contraceptives Behind the Blood-Testis Barrier (BTB) – Lesson from Adjudin
Current Medicinal Chemistry Relevance of Dyslipidaemia and its Consequences in Periodontal Patients with Co-Existing Cardiovascular Disease and Diabetes Mellitus: Therapeutic Targets
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Novel Anti-Inflammatory Agents in COPD: Targeting Lung and Systemic Inflammation
Current Drug Targets Long Term Complications in Pediatric Liver Transplant Recipients: What Every Pediatrician Should Know
Current Pediatric Reviews Future Targets in Endothelial Biology: Endothelial Cell to Mesenchymal Transition
Current Drug Targets Development of Inhibitors of the Aspartyl Protease Renin for the Treatment of Hypertension
Current Protein & Peptide Science Structure Activity Relationships for Nicotinamide in the Treatment of Stroke
Letters in Drug Design & Discovery Tolerability of Amine Uptake Inhibitors in Urologic Diseases
Current Drug Safety